Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Alzheimers Dement. 2016 Dec 27;13(7):783–791. doi: 10.1016/j.jalz.2016.11.006

Table 3.

Actigraphic assessment

Subjective sleep outcomes SCD, mean (SD) ±95% CI Controls, mean (SD) ± 95% CI F df R2 P Significant predictors
TIB (minutes) 486 (49) 468–503 480 (52) 463–497 2.43 5, 64 0.16 .044 Age
 Night-to-night variability   45 (20)   38–53   53 (22)   46–61 2.27 5, 64 0.15 .058
TST (minutes) 405 (46) 388–421 418 (49) 402–434 1.07 5, 64 0.08 .383
 Night-to-night variability*   44 (16)   38–49   49 (19)   42–55 1.72 5, 63 0.12 .143
SOL (minutes)*     9 (6)     7–12     6 (4)     5–7 4.34 5, 63 0.26 .002 Depressive symptoms, apnea risk
 Night-to-night variability*     9 (7)     7–12     6 (5)     4–7 2.76 5, 63 0.18 .026 Depressive symptoms
WASO (minutes)   69 (26)   60–79   55 (31)   45–66 2.42 5, 64 0.16 .044 SCD
 Night-to-night variability   27 (15)   22–33   23 (15)   18–28 1.60 5, 64 0.11 .172
N awakenings 16.3 (5.1) 14.5–18.2 15.0 (5.8) 13.1–16.9 1.27 5, 64 0.09 .286
 Night-to-night variability 4.5 (1.7) 3.8–5.1 4.5 (1.7) 4.0–5.0 0.71 5, 64 0.05 .620
Average length of the awakenings (minutes) 4.9 (2.3) 4.1–5.7 3.7 (1.0) 3.4–4.0 2.23 5, 64 0.15 .061
 Night-to-night variability 2.3 (1.9) 1.6–3.0 1.2 (0.7) 1.0–1.5 2.51 5, 64 0.16 .039 SCD
Awakening index 2.4 (0.7) 2.2–2.7 2.2 (0.9) 1.9–2.5 1.50 5, 64 0.11 .204
SE (%)   83 (5)   82–85   87 (6)   86–89 2.73 5, 64 0.18 .027 SCD
 Night-to-night variability*     6 (3)     5–7     5 (3)     4–5 1.80 5, 63 0.13 .125

Abbreviations: SCD, subjective cognitive decline; SD, standard deviation; CI, confidence interval; TIB, time in bed; TST, total sleep time; SOL, sleep onset latency; WASO, wake after sleep onset; SE, sleep efficiency.

*

One SCD participant has been excluded (value exceeding 3 SD of the mean).

Analysis based on log-transformed data.